NSN 6505-01-655-4271, 6505016554271
Cancelled -> Replaced by 6505001387344

Federal Supply Classification: FSC 6505 - Drugs and Biologicals
National Item Identification Number: NIIN 016554271
Codification Country: United States
Item Name Code: INC 32823
Criticality: (X) This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application.
Hazardous Material Indicator Code: (P) There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product.

Availability: Readily Available Qualified Suppliers: Currently qualifying suppliers

Manufacture or supply this part?
Join our growing community of certified suppliers.

Let Us Know

CALL ABOUT NSN 6505-01-655-4271

Our client representatives are standing by to help fulfill your request.

+1-321-773-5710

REQUEST QUOTE for 6505-01-655-4271

Have a list that needs to be quoted? Upload it here.

Upload a List

DLMS^® Summary

National Stock Number 6505-01-655-4271

National Stock Number (NSN) 6505-01-655-4271, or NIIN 016554271, (diatrizoate meglumine and diatri) was assigned May 26, 2016 in the Federal Logistics Information System (FLIS). This NIIN is Available for Manual Assignment. This NSN replaces 1 stock number, 6505001387344.

There are 5 manufacturer part numbers associated with this NSN. None of the associated part number(s) are considered obsolete. The manufacturer part numbers were originally supplied by one supplier. Today, one supplier is listed as an Active supplier for this NSN. Of the active suppliers, only one supplier is deemed design controlled or valid supply parts.

This part number has not been procured by the US Government in over 5 years, with the most recent procurement date of Aug 03, 2016. There has been one contract issued for this part number, with one award given. The US Government has only awarded those contracts to one supplier. The last contract numbers awarded were: SPE2DX15D9383. The total value of the awarded contracts has been US$ 2,667.25.

There has been a small amount of demand for this national stock number. The demand for this NSN originated from less than 5 countries. Based on a planned procurement review by the Primary Inventory Control Activity (PICA) on Jun 01, 2020, this NSN's acquisition method was noted as: Suitable for competitive acquisition for the first time. (Potential sources shall include dealers/distributors.) This part is a commercial/non-developmental/off-the-shelf-item. Valid AMCs: 1, 2, 3, 4 and 5.

This NSN is assigned to Item Name Code (INC) 32823. This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product. NSN 6505016554271 does not contain precious metals.

This NSN is associated to Schedule B 3006300000: opacifying preparations for x-ray examinations; diagnostic reageants designed to be administered to the patient. The Schedule B End Use is listed as pharmaceutical preparations. NAICS classification category 325412: pharmaceutical preparation manufacturing.

This information was last updated on Aug 01, 2025.

Technical Characteristics

ACTIVE MEDICAMENT MEDICINAL STRENGTH: (AKJA) 660.0 MILLIGRAMS DIATRIZOATE MEGLUMINE ACTIVE INGREDIENT AND 100.00 MILLIGRAMS DIATRIZOATE SODIUM ACTIVE INGREDIENT AND 0.125 MILLIGRAMS SODIUM PHOSPHATE, MONOBASIC ACTIVE INGREDIENT AND 0.11 MILLIGRAMS CALCIUM DISODIUM EDETATE ACTIVE INGREDIENT AND 3.65 MILLIGRAMS SODIUM PER MILLILITER AND 370.0 MILLIGRAMS IODINE ACTIVE INGREDIENT
ADMINISTRATION: (CSGS) INTRAVENOUS
FEATURES PROVIDED: (CBBL) STERILE
PHARMACEUTICAL VEHICLE TYPE: (AKJQ) AQUEOUS
MEDICAL DESIGNATION AND GRADE: (MDES) UNITED STATES PHARMACOPEIA
PRIMARY CONTAINER CONTENT QUANTITY: (CRLK) 200.0 MILLILITERS
PRIMARY CONTAINER TYPE: (CQCT) VIAL
PROTECTIVE STORAGE FEATURE: (AJCN) CONTROLLED ROOM TEMPERATURE
SPECIAL FEATURES: (FEAT) MD-76R, DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM INJECTION, USP; 200ML VIAL; 12 PER CASE; EACH MILLILITER OF THE CONTRAST AGENT CONTAINS 660 MG OF DIATRIZOATE MEGLUMINE AND 100 MG OF DIATRIZOATE SODIUM, 0.125 MG MONOBASIC SODIUM PHOSPHATE AND 0.11 MG EDETATE CALCIUM DISODIUM; THE SOLUTION CONTAINS APPROXIMATELY 3.65 MG (0.16 MEQ) SODIUM IN EACH MILLILITER AND 37% (370 MG/ML) ORGANICALLY BOUND IODINE; STORE AT CONTROLLED ROOM TEMPERATURE 20-25 C (68--77 F); STORE AWAY FROM HEAT AND LIGHT
TOTAL PRIMARY CONTAINER QUANTITY: (CSCW) 12
III PROTECTIVE STORAGE FEATURE: (AJCN) CONTROLLED ROOM TEMPERATURE